相关期刊:《Chinese Journal of Integrative Medicine》《Open Journal of Medical Microbiology》《Journal of Tuberculosis Research》《World Journal of Gastroenterology》更多>>
supported by the National Natural Science Foundation of China(No.32170403);the 111 Center from Ministry of Education of China and the State Administration of Foreign Experts Affairs of China(No.B18056);the“Double First-Class”University Project(No.CPU2018GF03);the Drug Innovation Major Project(Nos.2018ZX09711-001-007 and 2018ZX09735002-003)。
Two novel fungal metabolites,asperochones A and B,were obtained from an Aspergillus sp.Their structures were determined by 1D/2D nuclear magnetic resonance(NMR)spectroscopy,high resolution electrospray ionization mass...
Scientific Research Project of Heilongjiang Provincial Education Department(No.12531608)。
Objective:To study the effect of Yigan capsule on the expression of high mobility group protein B1(HMGB1),nuclear factor-B(NF-κB)and receptor for advanced glycation end products(RAGE)in anti-tuberculosis drug-induced...
sponsored by the National Research Foundation of Korea(NRF)Grant funded by the Korean government(MSIT)(Grant No.:2018R1A5A2021242).
The spread of tuberculosis(TB),especially multidrug-resistant TB and extensively drug-resistant TB,has strongly motivated the research and development of new anti-TB drugs.New strategies to facilitate drug combination...
funding support of this work by the Bill and Melinda Gates Foundation(No.INV-008413);the National Natural Science Foundation of China(No.21831005)and Shanghai Jiao Tong University.
TBAJ-876, developed by TB Alliance, a novel anti-tuberculosis-specific drug, has entered Phase II clinical trials. Herein, the first asymmetric synthesis of TBAJ-876 has been realized using synergistic Li/Li catalysis...
supported by the funds for the construction of key medical disciplines in Shenzhen.
Background and Aims:Anti-tuberculosis(anti-TB)druginduced liver injury(AT-DILI)is the most common side effect in patients who received anti-TB therapy.AT-DILI management includes monitoring liver function until sympto...
The emergence of drug-resistant tuberculosis has created an urgent need for new anti-tubercular agents. Here, we report thediscovery of a series of macrolides called sequanamycins with outstanding in vitro and in vivo...
Introduction: According to the literature consulted to date, there is epidemiological heterogeneity of Covid-19 between countries depending on their vaccination policy, in particular BCG vaccination. These findings ha...
BACKGROUND Solitary splenic tuberculosis(TB) is unusual and rarely reported.Whether splenic TB is best treated surgically is still controversial.We describe a 73-year-old man with solitary splenic TB and no extrapulmo...
The efficacy of levofloxacin combined with traditional anti-tuberculosis drugs was compared between the two groups. Methods: The trial was conducted between January 2021 and March 2022 and included a total of 78 patie...
Objective: to analyze the effect of anti tuberculosis plate combination drugs in the treatment of pulmonary tuberculosis. Methods: 62 patients with pulmonary tuberculosis (March November 2021) were randomly selected a...